CATALYST PHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Catalyst Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Catalyst Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 4, 2024 was 119M shares, a 11.9% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 119M +12.7M +11.9% Nov 4, 2024 10-Q 2024-11-06
Q2 2024 119M +12.1M +11.4% Aug 5, 2024 10-Q 2024-08-07
Q1 2024 118M +11.9M +11.2% Feb 26, 2024 10-K 2024-02-28
Q3 2023 107M +2.54M +2.44% Nov 6, 2023 10-Q 2023-11-08
Q2 2023 107M +3.76M +3.66% Aug 7, 2023 10-Q 2023-08-09
Q1 2023 106M +3.2M +3.11% Apr 17, 2023 10-K/A 2023-04-24
Q3 2022 104M +954K +0.93% Nov 7, 2022 10-Q 2022-11-09
Q2 2022 103M -159K -0.15% Aug 5, 2022 10-Q 2022-08-09
Q1 2022 103M -1.04M -1.01% Apr 27, 2022 10-K/A 2022-04-29
Q4 2021 103M Dec 31, 2021 10-K 2022-03-16
Q3 2021 103M -531K -0.51% Nov 5, 2021 10-Q 2021-11-09
Q2 2021 103M -485K -0.47% Aug 5, 2021 10-Q 2021-08-09
Q1 2021 104M +416K +0.4% Mar 11, 2021 10-K 2021-03-15
Q3 2020 104M +601K +0.58% Nov 5, 2020 10-Q 2020-11-09
Q2 2020 103M +534K +0.52% Aug 6, 2020 10-Q 2020-08-10
Q1 2020 103M +669K +0.65% Mar 12, 2020 10-K 2020-03-16
Q3 2019 103M +308K +0.3% Nov 8, 2019 10-Q 2019-11-12
Q2 2019 103M +330K +0.32% Aug 2, 2019 10-Q 2019-08-07
Q1 2019 103M +183K +0.18% Mar 14, 2019 10-K 2019-03-18
Q3 2018 103M +17.5M +20.5% Nov 2, 2018 10-Q 2018-11-07
Q2 2018 103M +18M +21.3% Aug 3, 2018 10-Q 2018-08-07
Q1 2018 103M +19.6M +23.6% Mar 9, 2018 10-K 2018-03-14
Q3 2017 85.2M +2.36M +2.85% Nov 3, 2017 10-Q 2017-11-08
Q2 2017 84.6M +1.68M +2.03% Aug 4, 2017 10-Q 2017-08-09
Q1 2017 83M +92K +0.11% Mar 10, 2017 10-K 2017-03-15
Q3 2016 82.9M +46.7K +0.06% Nov 4, 2016 10-Q 2016-11-09
Q2 2016 82.9M +395K +0.48% Aug 5, 2016 10-Q 2016-08-09
Q1 2016 82.9M +1.44M +1.76% Mar 11, 2016 10-K 2016-03-15
Q3 2015 82.8M +13.7M +19.8% Nov 6, 2015 10-Q 2015-11-09
Q2 2015 82.5M +15.3M +22.8% Aug 7, 2015 10-Q 2015-08-10
Q1 2015 81.4M +27.3M +50.4% Mar 10, 2015 10-K 2015-03-13
Q3 2014 69.1M +15M +27.7% Nov 7, 2014 10-Q 2014-11-13
Q2 2014 67.2M +25.7M +62% Aug 8, 2014 10-Q 2014-08-13
Q1 2014 54.1M +12.7M +30.7% Mar 14, 2014 10-K 2014-03-19
Q3 2013 54.1M +19.4M +55.8% Nov 8, 2013 10-Q 2013-11-13
Q2 2013 41.5M +10.7M +34.9% Aug 9, 2013 10-Q 2013-08-14
Q1 2013 41.4M +16.7M +67.4% Apr 1, 2013 10-K 2013-04-01
Q3 2012 34.8M +10.1M +40.7% Nov 9, 2012 10-Q 2012-11-14
Q2 2012 30.7M +9.09M +42% Aug 10, 2012 10-Q 2012-08-14
Q1 2012 24.7M Mar 23, 2012 10-K 2012-03-30
Q3 2011 24.7M Nov 11, 2011 10-Q 2011-11-14
Q2 2011 21.7M Aug 12, 2011 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.